EVANS SYNDROME
Clinical trials for EVANS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new EVANS SYNDROME trials appear
Sign up with your email to follow new studies for EVANS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at stubborn blood disorders
Disease control Recruiting nowThis early-phase study tests a new treatment called RD06-05, which uses specially engineered immune cells (CAR-T cells) to target and destroy the faulty cells causing autoimmune blood diseases. The trial includes 27 adults with conditions like immune thrombocytopenia, autoimmune …
Matched conditions: EVANS SYNDROME
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 17, 2026 07:34 UTC
-
New antibody therapy targets hard-to-treat blood disorders
Disease control Recruiting nowThis study tests a new drug called CM336 for people with certain blood disorders (like low platelets or anemia) that have come back or not responded to other treatments. The drug works by helping the immune system stop attacking the body's own blood cells. About 158 adults will t…
Matched conditions: EVANS SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated May 11, 2026 20:38 UTC